{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:30:35Z","timestamp":1786987835604,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.dsx.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T17:17:39Z","timestamp":1413134259000},"page":"266-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population"],"prefix":"10.1016","volume":"9","author":[{"given":"Sedigheh","family":"Asgary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Ziaedin","family":"SamsamShariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.dsx.2014.09.007_bib0005","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.dsx.2014.09.007_bib0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute\/American Heart Association Conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2014.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2741\/3812","article-title":"Inflammatory markers and cardiovascular risk in the metabolic syndrome","volume":"16","author":"Espinola-Klein","year":"2010","journal-title":"Front Biosci"},{"issue":"7","key":"10.1016\/j.dsx.2014.09.007_bib0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1586\/erc.12.74","article-title":"Obesity and metabolic syndrome as related to cardiovascular disease","volume":"10","author":"Nikolopoulou","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"10.1016\/j.dsx.2014.09.007_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0148607108325251","article-title":"Adipose inflammation, insulin resistance, and cardiovascular disease","volume":"32","author":"Shah","year":"2008","journal-title":"J Parenter Enteral Nutr"},{"issue":"6818","key":"10.1016\/j.dsx.2014.09.007_bib0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.dsx.2014.09.007_bib0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.2001.6015","article-title":"Decreased resistin expression in mice with different sensitivities to a high-fat diet","volume":"289","author":"Lay","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"28","key":"10.1016\/j.dsx.2014.09.007_bib0040","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor \u03b3 agonists","volume":"276","author":"Way","year":"2001","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.dsx.2014.09.007_bib0045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.dsx.2014.09.007_bib0050","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/sj.ki.5000089","article-title":"Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance","volume":"69","author":"Axelsson","year":"2006","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.dsx.2014.09.007_bib0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.ijo.0803037","article-title":"Relationships between human serum resistin, inflammatory markers and insulin resistance","volume":"29","author":"Bo","year":"2005","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.dsx.2014.09.007_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2840-4-10","article-title":"Serum resistin is associated with C-reactive protein and LDL-cholesterol in type 2 diabetes and coronary artery disease in a Saudi population","volume":"4","author":"Al-Daghri","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dsx.2014.09.007_bib0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.metabol.2007.11.010","article-title":"Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults","volume":"57","author":"Aquilante","year":"2008","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.dsx.2014.09.007_bib0070","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2005-0293","article-title":"Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance","volume":"90","author":"Pagano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.dsx.2014.09.007_bib0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1464-5491.2004.01261.x","article-title":"Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects","volume":"21","author":"Matsuda","year":"2004","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.dsx.2014.09.007_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jc.2005-1653","article-title":"Cross-sectional associations of resistin, coronary heart disease, and insulin resistance","volume":"91","author":"Burnett","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1463-1326.2004.00410.x","article-title":"Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia","volume":"7","author":"Farvid","year":"2005","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.dsx.2014.09.007_bib0090","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00125-005-1932-y","article-title":"Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans","volume":"48","author":"Utzschneider","year":"2005","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.dsx.2014.09.007_bib0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1507\/endocrj.52.519","article-title":"Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children","volume":"52","author":"Zou","year":"2005","journal-title":"Endocr J"},{"issue":"7","key":"10.1016\/j.dsx.2014.09.007_bib0100","first-page":"259","article-title":"Human resistin: found in translation from mouse to man","volume":"22","author":"Schwartz","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2143\/AC.58.4.2005288","article-title":"Isfahan Healthy Heart Program: a comprehensive integrated community-based program for cardiovascular disease prevention and control","volume":"58","author":"Sarraf-Zadegan","year":"2003","journal-title":"Acta Cardiol"},{"issue":"2","key":"10.1016\/j.dsx.2014.09.007_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.precon.2006.10.003","article-title":"Isfahan Healthy Heart Program: evaluation of comprehensive, community-based interventions for non-communicable disease prevention","volume":"2","author":"Sarrafzadegan","year":"2006","journal-title":"Prev Control"},{"issue":"6","key":"10.1016\/j.dsx.2014.09.007_bib0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"23","key":"10.1016\/j.dsx.2014.09.007_bib0120","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)","volume":"269","author":"Grundy","year":"1993","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.dsx.2014.09.007_bib0125","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.dsx.2014.09.007_bib0130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"issue":"147","key":"10.1016\/j.dsx.2014.09.007_bib0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1470173","article-title":"Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women","volume":"1","author":"Matsubara","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"29","key":"10.1016\/j.dsx.2014.09.007_bib0140","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota","year":"2002","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.dsx.2014.09.007_bib0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/oby.2003.137","article-title":"Correlation between serum resistin level and adiposity in obese individuals","volume":"11","author":"Azuma","year":"2003","journal-title":"Obes Res"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.dsx.2014.09.007_bib0155","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.dsx.2014.09.007_bib0160","first-page":"161","article-title":"Serum resistin is not associated with obesity or insulin resistance in humans","volume":"9","author":"Iqbal","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.dsx.2014.09.007_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02338","article-title":"Plasma resistin levels correlate with determinants of the metabolic syndrome","volume":"156","author":"Norata","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/met.2011.0128","article-title":"Association of resistin with metabolic syndrome in Indian subjects","volume":"10","author":"Singh","year":"2012","journal-title":"Metab Syndr Relat Disord"},{"issue":"1 Suppl.","key":"10.1016\/j.dsx.2014.09.007_bib0175","article-title":"Association of resistin and hs-CRP with liver enzymes and components of the metabolic syndrome in Iranian adolescents with excess weight: the CASPIAN-III Study","volume":"29","author":"Kelishadi","year":"2013","journal-title":"Pak J Med Sci"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0180","first-page":"630","article-title":"Resistin levels and inflammatory markers in patients with morbid obesity","volume":"25","author":"Luis","year":"2010","journal-title":"Nutr Hosp"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000354574","article-title":"Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome","volume":"6","author":"Makni","year":"2013","journal-title":"Obes Facts"},{"issue":"2","key":"10.1016\/j.dsx.2014.09.007_bib0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.29333\/ejgm\/82707","article-title":"Ghrelin, resistin and leptin levels in patients with metabolic syndrome","volume":"8","author":"Ko\u00e7","year":"2011","journal-title":"Eur J Gen Med"},{"issue":"4","key":"10.1016\/j.dsx.2014.09.007_bib0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.metabol.2004.10.015","article-title":"Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters","volume":"54","author":"Chen","year":"2005","journal-title":"Metabolism"},{"issue":"February","key":"10.1016\/j.dsx.2014.09.007_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-14-39","article-title":"The relationship between hepatic resistin over expression and inflammation in patients with nonalcoholic steatohepatitis","volume":"14","author":"Shen","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.dsx.2014.09.007_bib0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20050078","article-title":"Role of resistin in obesity, insulin resistance and type II diabetes","volume":"109","author":"Kusminski","year":"2005","journal-title":"Clin Sci"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T14:42:25Z","timestamp":1598366545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402114000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1871402114000848"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2014.09.007","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Diabetes India. Published by Diabetes India All rights reserved.","name":"copyright","label":"Copyright"}]}}